Thirtyfivebio
Thirtyfivebio is a startup headquartered in Abingdon, United Kingdom, founded in 2021. It has won about £959k in competitive Innovate UK grants since 2023, according to UK Research and Innovation.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Innovation grants
Thirtyfivebio has won about £959k in competitive Innovate UK grants since 2023.
- Precision Medicine Approach and Enhanced Patient Stratification for Ulcerative Colitis and Colorectal Cancer via GPR35 inhibition (£463k, 2024)
- Enabling translational studies and clinical entry plan in gastro-intestinal inflammatory diseases and cancers for human GPR35 antagonist lead molecules. (£495k, 2023)
R&D ecosystem
Thirtyfivebio sits inside the London and the Golden Triangle R&D ecosystem in the Global R&D Labs Directory.
Other startups in Abingdon
Related
Questions and answers
What does Thirtyfivebio do?
Thirtyfivebio works in biotechnology. Its Innovate UK projects include: Precision Medicine Approach and Enhanced Patient Stratification for Ulcerative Colitis and Colorectal Cancer via GPR35 inhibition.
Where is Thirtyfivebio based?
Thirtyfivebio is headquartered in Abingdon, United Kingdom.
When was Thirtyfivebio founded?
Thirtyfivebio was founded in 2021.
Source records: Companies House and UK Research and Innovation.
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.